RBM Partnership welcomes Ambassador Dybul as new Executive Director of the Global Fund
15 November 2012, Geneva, SWITZERLAND: - The RBM Partnership welcomes the appointment of Ambassador Mark Dybul as the new Executive Director of the Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund).
"Ambassador Dybul has a wealth of experience and demonstrated leadership in global public health. As the former United States Global AIDS Coordinator, he has a deep appreciation of country level programs, including those for malaria control. The RBM Board looks forward to working with him and to continuing its close collaboration with the Global Fund Board that has enabled millions of people to access lifesaving malaria prevention and treatment," said Dr Fatoumata Nafo-Traoré, Executive Director of the Roll Back Malaria Partnership.
Dr Dybul led the implementation of the President’s Emergency Plan for AIDS Relief (PEPFAR), the largest international health initiative for a single disease. He oversaw US government engagement in the Global Fund and was Chair of the Finance and Audit Committee. Dr Dybul was also a member of the Planning Task Force that created PEPFAR and a principal architect of its initial plan. At present, Dr Dybul co-directs the Global Health Law Program at the O’Neill Institute for National and Global Health Law at Georgetown University, where he is a distinguished scholar.
As the new Executive Director of the Global Fund, Dr Dybul will lead the integration the lessons learned from Phase 1 of the Affordable Medicines Facility for malaria (AMFm) into core Global Fund grant management and financial processes. The AMFm was created to improve access to artemisinin-based combination therapies (ACTs) and helped decrease drug prices through a factory-gate subsidy on behalf of buyers in selected pilot countries. With the integration of the AMFm model into Global Fund processes, there will no longer be a separate fund with external donor contributions to cover co-payments.